U.S. patent application number 11/352152 was filed with the patent office on 2008-05-29 for ribonucleic acid interference molecules.
This patent application is currently assigned to International Business Machines Corporation. Invention is credited to Tien Huynh, Kevin Charles Miranda, Isidore Rigoutsos.
Application Number | 20080125583 11/352152 |
Document ID | / |
Family ID | 36793801 |
Filed Date | 2008-05-29 |
United States Patent
Application |
20080125583 |
Kind Code |
A1 |
Rigoutsos; Isidore ; et
al. |
May 29, 2008 |
Ribonucleic acid interference molecules
Abstract
Ribonucleic acid interference molecules are provided. For
example, in one aspect of the invention, at least one nucleic acid
molecule comprising at least one of one or more precursor sequences
having SEQ ID NO: 1 through SEQ ID NO: 103,948 and one or more
mature sequences having SEQ ID NO: 1 through SEQ ID NO: 126,499 is
provided. One or more of the at least one of one or more precursor
sequences and one or more mature sequences may be computationally
predicted, e.g., from publicly available genomes, using a pattern
discovery method. In another aspect of the invention, a method for
regulating gene expression comprises the following step. At least
one nucleic acid molecule comprising at least one of one or more
precursor sequences having SEQ ID NO: 1 through SEQ ID NO: 103,948,
each one of the precursor sequences containing one or more mature
sequences having SEQ ID NO: 1 through SEQ ID NO: 126,499, is used
to regulate the expression of one or more genes, e.g., by inducing
post-transcriptional silencing of the one or more genes.
Inventors: |
Rigoutsos; Isidore;
(Astoria, NY) ; Huynh; Tien; (Yorktown, NY)
; Miranda; Kevin Charles; (McDowall, AU) |
Correspondence
Address: |
Ryan, Mason & Lewis, LLP
90 Forest Avenue
Locust Valley
NY
11560
US
|
Assignee: |
International Business Machines
Corporation
Armonk
NY
|
Family ID: |
36793801 |
Appl. No.: |
11/352152 |
Filed: |
February 10, 2006 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
60652499 |
Feb 11, 2005 |
|
|
|
Current U.S.
Class: |
536/22.1 |
Current CPC
Class: |
G16B 20/00 20190201;
C12N 2310/14 20130101; C12N 2320/11 20130101; G16B 40/00 20190201;
G16B 30/00 20190201; G16B 15/00 20190201; C12N 15/111 20130101;
C12N 2330/10 20130101 |
Class at
Publication: |
536/22.1 |
International
Class: |
C07H 21/04 20060101
C07H021/04 |
Claims
1. At least one nucleic acid molecule, comprising: at least one of
one or more precursor sequences having SEQ ID NO: 1 through SEQ ID
NO: 103,948 and one or more mature sequences having SEQ ID NO:
103,949 through SEQ ID NO: 230,447.
2. The at least one nucleic acid molecule of claim 1, wherein one
or more of the at least one of one or more precursor sequences and
one or more mature sequences have been computationally predicted
using a pattern discovery method.
3. The at least one nucleic acid molecule of claim 1, wherein one
or more of the at least one of one or more precursor sequences and
one or more mature sequences regulate gene expression in one or
more genes by inducing post-transcriptional silencing of the one or
more genes.
4. The at least one nucleic acid molecule of claim 1, wherein one
or more of the sequences encode ribonucleic acid sequences.
5. The at least one nucleic acid molecule of claim 1, wherein one
or more of the sequences encode interfering ribonucleic acid
sequences.
6. The at least one nucleic acid molecule of claim 1, wherein the
precursor sequences having SEQ ID NO: 1 through SEQ ID NO: 57,431
are derived from a genomic sequence corresponding to H.
sapiens.
7. The at least one nucleic acid molecule of claim 1, wherein the
precursor sequences having SEQ ID NO: 57,432 through SEQ ID NO:
101,967 are derived from a genomic sequence corresponding to M.
musculus.
8. The at least one nucleic acid molecule of claim 1, wherein the
precursor sequences having SEQ ID NO: 101,968 through SEQ ID NO:
103,203 are derived from a genomic sequence corresponding to D.
melanogaster.
9. The at least one nucleic acid molecule of claim 1, wherein the
precursor sequences having SEQ ID NO: 103,204 through SEQ ID NO:
103,948 are derived from a genomic sequence corresponding to C.
elegans.
10. The at least one nucleic acid molecule of claim 1, wherein the
mature sequences having SEQ ID NO: 103,949 through SEQ ID NO:
173,336 are derived from a genomic sequence corresponding to H.
sapiens.
11. The at least one nucleic acid molecule of claim 1, wherein the
mature sequences having SEQ ID NO: 173,337 through SEQ ID NO:
228,005 are derived from a genomic sequence corresponding to M.
musculus.
12. The at least one nucleic acid molecule of claim 1, wherein the
mature sequences having SEQ ID NO: 228.006 through SEQ ID NO:
229,484 are derived from a genomic sequence corresponding to D.
melanogaster.
13. The at least one nucleic acid molecule of claim 1, wherein the
mature sequences having SEQ ID NO: 229,485 through SEQ ID NO:
230,447 are derived from a genomic sequence corresponding to C.
elegans.
14. A method for regulating gene expression, the method comprising
the step of: using at least one nucleic acid molecule, comprising
at least one of one or more precursor sequences having SEQ ID NO: 1
through SEQ ID NO: 103,948 or one or more mature sequences having
SEQ ID NO: 103,949 through SEQ ID NO: 230,447 to regulate the
expression of one or more genes.
15. The method of claim 14, further comprising the step of
inserting the at least one nucleic acid molecule into an
environment where the at least one nucleic acid molecule can be
produced biochemically.
16. The method of claim 14, further comprising the step of
inserting the at least one nucleic acid molecule in to an
environment where the at least one nucleic acid molecule can be
produced biochemically, giving rise to one or more interfering
ribonucleic acids which affect one or more target sequences.
17. The method of claim 14, wherein one or more of the sequences
are synthetically removed from the genome that contains them
naturally.
18. The method of claim 14, wherein one or more of the sequences
are synthetically introduced in a genome that does not contain them
naturally.
19. The method of claim 14, wherein one or more target sequences
are encoded by a same genome as the one or more sequences.
20. The method of claim 14, wherein one or more target sequences
are encoded by a different genome from the one or more
sequences.
21. The method of claim 14, wherein one or more sequences are
transcribed, giving rise to one or more interfering ribonucleic
acids which induce post-transcriptional repression of one or more
target sequences.
22. The method of claim 14, wherein the one or more sequences are
transcribed, giving rise to one or more interfering ribonucleic
acids which induce gene silencing of one or more target
sequences.
23. The method of claim 14, wherein one or more target sequences
are naturally occurring.
24. The method of claim 14, wherein one or more target sequences
are synthetically constructed.
25. The method of claim 14, wherein one or more of the sequences
are synthetically constructed.
26. At least one nucleic acid molecule, comprising: at least a
portion of a precursor sequence having one of SEQ ID NO: 1 through
SEQ ID NO: 103,948, wherein the portion comprises an amount of the
sequence that does not significantly alter a behavior of the
complete precursor sequence.
27. At least one nucleic acid molecule, comprising: at least a
portion of a mature sequence having one of SEQ ID NO: 103,949
through SEQ ID NO: 230,447, wherein the portion comprises an amount
of the sequence that does not significantly alter a behavior of the
complete mature sequence.
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional
Application No. 60/652,499, filed Feb. 11, 2005, the disclosure of
which is incorporated by reference herein.
[0002] This application is related to U.S. patent application
entitled "System and Method for Identification of MicroRNA Target
Sites and Corresponding Targeting MicroRNA," (attorney docket no.
YOR920060077US1), and to U.S. patent application entitled "System
and Method for Identification of MicroRNA Precursor Sequences and
Corresponding Mature MicroRNA Sequences from Genomic Sequences"
(attorney docket no. YOR920060075US1), both filed concurrently
herewith, the disclosures of which are incorporated by reference
herein.
FIELD OF THE INVENTION
[0003] The present invention relates to genes and, more
particularly, to ribonucleic acid interference molecules and their
role in gene expression.
BACKGROUND OF THE INVENTION
[0004] The ability of an organism to regulate the expression of its
genes is of central importance to life. A breakdown in this
homeostasis leads to disease states, such as cancer, where a cell
multiplies uncontrollably, to the detriment of the organism. The
general mechanisms utilized by organisms to maintain this gene
expression homeostasis are the focus of intense scientific
study.
[0005] It recently has been discovered that some cells are able to
down-regulate their gene expression through certain ribonucleic
acid (RNA) molecules. Namely, RNA molecules can act as potent gene
expression regulators either by inducing mRNA degradation or by
inhibiting translation; this activity is summarily referred to as
post-transcriptional gene silencing or PTGS for short. An
alternative name by which it is also known is RNA interference, or
RNAi. PTGS/RNAi has been found to function as a mediator of
resistance to endogenous and exogenous pathogenic nucleic acids and
also as a regulator of the expression of genes inside cells.
[0006] The term `gene expression,` as used herein, refers generally
to the transcription of messenger-RNA (mRNA) from a gene, and its
subsequent translation into a functional protein. One class of RNA
molecules involved in gene expression regulation comprises
microRNAs, which are endogenously encoded and regulate gene
expression by either disrupting the translation processes or by
degrading mRNA transcripts, e.g., inducing post-transcriptional
repression of one or more target sequences.
[0007] The RNAi/PTGS mechanism allows an organism to employ short
RNA sequences to either degrade or disrupt translation of
complementary mRNA transcripts. Early studies suggested only a
limited role for RNAi, that of a defense mechanism against
pathogens. However, the subsequent discovery of many
endogenously-encoded microRNAs pointed towards the possibility of
this being a more general, in nature, control mechanism. Recent
evidence has led the community to hypothesize that a wider spectrum
of biological processes are affected by RNAi, thus extending the
range of this presumed control layer.
[0008] A better understanding of the mechanism of the RNA
interference process would benefit drug design, the fight against
disease, and the understanding of host defense mechanisms.
SUMMARY OF THE INVENTION
[0009] Ribonucleic acid interference molecules are provided. For
example, in one aspect of the invention, at least one nucleic acid
molecule comprising at least one of one or more precursor sequences
having SEQ ID NO: 1 through SEQ ID NO: 103,948 and one or more
mature sequences having SEQ ID NO: 1 through SEQ ID NO: 126,499 is
provided. For example, molecules may be one or more instances of a
precursor type, one or more instances of a mature type, or some
combinations thereof. One or more of the sequences may be
computationally predicted, e.g., from publicly available genomes,
using a pattern discovery method.
[0010] It is to be understood that "SEQ ID NO." stands for sequence
identification number. Each sequence identification number
corresponds to a sequence stored in a text file on the accompanying
CDROM.
[0011] In another aspect of the invention, a method for regulating
gene expression comprises the following step. At least one nucleic
acid molecule comprising at least one of one or more precursor
sequences having SEQ ID NO: 1 through SEQ ID NO: 103,948, each one
of the precursor sequences containing one or more mature sequences
having SEQ ID NO: 1 through SEQ ID NO: 126,499, is used to regulate
the expression of one or more genes.
[0012] The method may further comprise inserting the at least one
nucleic acid molecule into an environment where the at least one
nucleic acid molecule can be produced biochemically. The method may
further comprise inserting the at least one nucleic acid molecule
in to an environment where the at least one nucleic acid molecule
can be produced biochemically, giving rise to one or more
interfering ribonucleic acids which affect one or more target
sequences.
[0013] One or more of the sequences may be synthetically removed
from the genome that contains them naturally. One or more of the
sequences may be synthetically introduced in a genome that does not
contain them naturally.
[0014] One or more target sequences may be encoded by the same
genome as the one or more sequences. One or more target sequences
may be encoded by a different genome from the one or more
sequences. One or more target sequences are naturally occurring.
One or more target sequences may be synthetically constructed.
[0015] One or more sequences may be transcribed, giving rise to one
or more interfering ribonucleic acids which induce
post-transcriptional repression of one or more target sequences.
One or more sequences may be transcribed, giving rise to one or
more interfering ribonucleic acids which induce gene silencing of
one or more target sequences. One or more of the sequences may be
synthetically constructed.
[0016] In a yet another aspect of the invention, at least one
nucleic acid molecule comprises at least a portion of a precursor
sequence having one of SEQ ID NO: 1 through SEQ ID NO: 103,948,
wherein the portion comprises an amount of the sequence that does
not significantly alter a behavior of the complete precursor
sequence.
[0017] In a further aspect of the invention, at least one nucleic
acid molecule comprises at least a portion of a mature sequence
having one of SEQ ID NO: 1 through SEQ ID NO: 126,499, wherein the
portion comprises an amount of the sequence that does not
significantly alter a behavior of the complete mature sequence.
[0018] A more complete understanding of the present invention, as
well as further features and advantages of the present invention,
will be obtained by reference to the following detailed
description.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0019] The teachings of the present invention relate to ribonucleic
acid (RNA) molecules and their role in gene expression regulation.
The term `gene expression,` as used herein, refers generally to the
transcription of messenger-RNA (mRNA) from a gene, and, e.g., its
subsequent translation into a functional protein. One class of RNA
molecules involved in gene expression regulation comprises
microRNAs, which are endogenously encoded and regulate gene
expression by either disrupting the translation processes or by
degrading mRNA transcripts, e.g., inducing post-transcriptional
repression of one or more target sequences. MicroRNAs are
transcribed by RNA polymerase II as parts of longer primary
transcripts known as pri-microRNAs. Pri-microRNAs are subsequently
cleaved by Drosha, a double-stranded-RNA-specific ribonuclease, to
form microRNA precursors or pre-microRNAs. Pre-microRNAs are
exported by Exportin-5 from the nucleus into the cytoplasm where
they are processed by Dicer. Dicer is a member of the RNase III
family of nucleases that cleaves the pre-microRNA and forms a
double-stranded RNA with overhangs at the 3' of both ends that are
one to four nucleotides long. The mature microRNA is derived from
either the leading or the lagging arm of the microRNA precursor.
Finally, a helicase separates the double-stranded RNA species into
single-stranded and the strand containing the mature microRNA
becomes associated with an effector complex known as RISC (for
RNA-induced silencing complex). The RISC+microRNA construct base
pairs with its target in a sequence-specific manner using
Watson-Crick pairing (and the occasional formation of G:U pairs).
If the microRNA is loaded into an Argonaute-2 RISC, the target is
cleaved at the binding site and degraded. In the presence of
mismatches between a microRNA and its target, post-transcriptional
gene silencing is effected through translational inhibition.
[0020] According to the teachings presented herein, the target
sequence(s) may be naturally occurring. Alternatively, the target
sequences may be synthetically constructed. A target sequence may
be synthetically constructed so as to test prediction methods
and/or to induce the RNAi/PTGS control of genes of interest.
Additionally, a target sequence may be synthetically constructed so
as to control multiple genes with a single RNA molecule, and also
possibly to modify, in a combinatorial manner, the kinetics of the
reaction by, for example, introducing multiple target sites.
Similarly, the precursor sequence(s) may be either naturally
occurring or synthetically constructed. For example, a precursor
sequence of interest may be synthetically constructed and
introduced into a cell that lacks that particular precursor.
Further, when any of the above sequences are naturally occurring,
they may be synthetically removed, for analysis purposes, from the
genome that contains them, e.g., using standard molecular
techniques.
[0021] As mentioned above, the present application is related to
U.S. patent application entitled "System and Method for
Identification of MicroRNA Target Sites and Corresponding Targeting
MicroRNA," (attorney docket no. YOR920060077US1), and to U.S.
patent application entitled "System and Method for Identification
of MicroRNA Precursor Sequences and Corresponding Mature MicroRNA
Sequences from Genomic Sequences" (attorney docket no.
YOR920060075US1), both filed concurrently herewith, the disclosures
of which are incorporated by reference herein.
[0022] In such related applications, several important questions
are addressed. For example, for a given nucleotide sequence, is it
part of or does it contain a microRNA precursor? Or, given the
sequence of a microRNA precursor, where is the segment which will
give rise to the mature microRNA? Further, is there more than one
mature microRNA produced by a particular precursor, and if so,
where are the segments which, after transcription, will give rise
to these additional mature microRNAs? Another question addressed is
the following: given the 3' untranslated region (3'UTR) of a given
gene, which region(s) of it will function as a target(s) for some
mature microRNA? This last question can also be asked when we are
instead presented with the 5' untranslated region (5'UTR) or the
amino acid coding region of a given gene. Also, for a given
putative target site, which microRNA, if any, will bind to the
putative target site?
[0023] For the purposes of this discussion, we only focus on the
problem of whether a specific nucleotide sequence corresponds to a
microRNA precursor or to a mature microRNA. A method for answering
this question is described in the above referenced YOR920060075US1
patent application.
[0024] Summarily, the method comprises a first phase during which
patterns are generated by processing an appropriate training set
using a pattern discovery algorithm. If the training set comprises
sequences of microRNA precursors, then the generated patterns,
after appropriate attribute-based filtering, will be
microRNA-precursor specific. If the training set comprises
sequences of mature microRNAs, then the generated patterns, after
appropriate attribute-based filtering, will be mature-microRNA
specific. Alternatively, the training set can comprise putative
mature microRNAs or putative microRNA precursors. In a preferred
embodiment, two training sets were used, one comprising sequences
of known microRNA precursors and one comprising sequences of known
mature microRNAs.
[0025] The basic idea of this pattern-based method is to replace
the training set of sequences with an "equivalent" representation
that consists of patterns. The patterns can be derived using a
pattern discovery algorithm, such as the Teiresias algorithm. See,
for example, U.S. Pat. No. 6,108,666 issued to A. Floratos and I.
Rigoutsos, entitled "Method and Apparatus for Pattern Discovery in
1-Dimensional Event Streams," the disclosure of which is
incorporated by reference herein. The patterns are, ideally,
maximal in composition and length (properties which are, by
default, guaranteed by the Teiresias algorithm).
[0026] The generated microRNA-precursor-specific or
mature-microRNA-specific patterns can then be used as predicates to
identify, in a de novo manner, microRNA precursors from genomic
sequence, or mature microRNAs in the sequence of a putative
microRNA precursor. This is exploited in the method's second phase
during which the patterns at hand are sought in the sequence under
consideration: to determine whether a given nucleotide sequence S
is part of, or encodes, a microRNA precursor the
microRNA-precursor-specific patterns are used; and to determine
whether a given nucleotide sequence S corresponds to, or contains a
mature microRNA mature-microRNA-specific patterns are used.
[0027] In general, one anticipates numerous instances of
microRNA-precursor-specific patterns in sequences that correspond
to microRNA precursors whereas background and unrelated sequences
should receive few or no such hits. If the number of pattern
instances exceeds a predetermined threshold, then the corresponding
segment of the sequence that receives the pattern support (and
possibly an appropriately sized flanking region) is reported as a
putative microRNA precursor. Analogous comments can be made about
mature-microRNA-specific patterns and sequences containing mature
microRNAs.
[0028] In the present application, pattern-discovery techniques,
such as those described above, have been used in conjunction with
recently released, publicly available genomic sequences to predict
microRNA precursor and mature miRNA sequences related to the
following organisms: C. elegans (Wormbase release 140); D.
melanogaster (Berkely Drosophila Genome Project release 3.2); M.
musculus (Ensembl assembly based on the NCBI 31 assembly); and H.
sapiens (Ensembl assembly based on the NCBI 31 assembly). Namely,
precursor sequences having SEQ ID NO: 1 through SEQ ID NO: 57,431
derived from the genome of H. sapiens are presented; precursor
sequences having SEQ ID NO: 57,432 through SEQ ID NO: 101,967
derived from the genome of M. musculus are presented; precursor
sequences having SEQ ID NO: 101,968 through SEQ ID NO: 103,203
derived from the genome of D. melanogaster are presented; precursor
sequences having SEQ ID NO: 103,204 through SEQ ID NO: 103,948
derived from the genome of C. elegans are presented; mature
sequences having SEQ ID NO: 1 through SEQ ID NO: 69,388 derived
from the genome of H. sapiens are presented; mature sequences
having SEQ ID NO: 69,389 through SEQ ID NO: 124,057 derived from
the genome of M. musculus are presented; mature sequences having
SEQ ID NO: 124,058 through SEQ ID NO: 125,536 derived from the
genome of D. melanogaster are presented; and mature sequences
having SEQ ID NO: 125,537 through SEQ ID NO: 126,499 derived from
the genome of C. elegans are presented.
[0029] These predicted precursor and mature sequences are submitted
herewith in electronic text format as the files ALL_MATURES.txt,
created on Friday, Feb. 10, 2006, having a size of 11.4 Megabytes,
and ALL_PRECURSORS.txt, Friday, Feb. 10, 2006, having a size of
14.5 Megabytes, on compact disc (CDROM), the contents of which are
incorporated by reference herein. Two identical copies of the
sequences are submitted herewith.
[0030] With respect to the sequences submitted herewith, for each
precursor sequence that is listed, five features are presented (in
addition to the sequence ID number and the corresponding organism
name). One, the chromosome number (e.g., the chromosome identifier)
is displayed. Two, the precursor start and end points on the
corresponding chromosome are denoted. Three, the strand, either
forward or reverse, on which the precursor will be found, is
listed. Four, since the sequences displayed are predicted to fold
into hairpin-like shapes, the predicted folding energy (also known
as the energy required to denature the precursor) is presented.
Five, each precursor sequence is presented.
[0031] As above, with respect to the sequences submitted herewith,
for each mature sequence predicted, six features are presented (in
addition to the sequence ID number and the corresponding organism
name). One, as above, the chromosome number, (e.g., chromosome
identifier) is displayed. Two, as above, the start and end points
of the corresponding precursor sequence on the corresponding
chromosome are denoted. Three, as above, the strand, either forward
or reverse, on which the corresponding precursor will be found is
listed. Four, as above, since the sequences displayed are derived
from precursors which are predicted to fold into hairpin-like
shapes, the folding energy of the corresponding precursor (also
known as the energy required to denature the precursor) is
presented. Five, the start and end points of the mature sequence on
the corresponding chromosome are denoted. Six, each mature sequence
is presented.
[0032] All of the sequences presented herein, whether precursors or
matures, are deoxyribonucleic acid (DNA) sequences. One of ordinary
skill in the art would easily be able to derive the RNA transcripts
corresponding to these DNA sequences. As such, the RNA forms of
these DNA sequences are considered to be within the scope of the
present teachings. Also, it should be understood that the locations
of the described sequences are given in the form of global
coordinates, i.e., in terms of distances from the leftmost tip of
the forward strand in the chromosome where the sequence at hand is
located. In other words, all of the stated coordinates use the
beginning of each chromosome's forward strand as a point of
reference. If a sequence is reported to be on the reverse strand
between locations X and Y, then one can actually generate the
actual nucleotide sequence for it by excising the string contained
between locations X and Y of the forward strand and then generating
its reverse complement. These global coordinates are likely to
change from one release of the genomic assembly to the next.
Nonetheless, even though its actual location may change, the actual
sequence that corresponds to a microRNA precursor or a mature
microRNA is expected to remain unique and thus the corresponding
sequence's new location will still be identifiable (except of
course for the case where the sequence at hand corresponds to a
segment that has been removed from the genomic assembly that is
being examined).
[0033] One of ordinary skill in the art would also recognize that
sequences that are either homologous or orthologous to the
sequences presented herein, e.g., sequences that are related by
vertical descent from a common ancestor or through other means
(e.g., through horizontal gene transfer), will likely be present in
genomes other than the ones mentioned herein. Such
homologous/orthologous sequences are expected to generally differ
from the sequences listed herein by only a small number of
locations. Thus, the teachings presented herein should be construed
as being broadly applicable to such homologous/orthologous
sequences from species other than those listed above.
[0034] According to an exemplary embodiment, nucleic acid molecules
may be generated based on the predicted precursor and mature
sequences. The nucleic acid molecules generated may then be used to
regulate gene expression. For example, as described generally
above, mechanisms exist by which RNA molecules effect the
expression of genes. By way of example only, the nucleic acid
molecules generated may regulate the expression of a gene, or
genes, by inducing post-transcriptional silencing of the gene, e.g.
as described above. Using the predicted precursor and mature
sequences to study gene expression may be conducted using
techniques and procedures commonly known to those skilled in the
art.
[0035] Although illustrative embodiments of the present invention
have been described herein, it is to be understood that the
invention is not limited to those precise embodiments, and that
various other changes and modifications may be made by one skilled
in the art without departing from the scope or spirit of the
invention. For example, one may modify one or more of the described
precursor sequences by adding or removing a number of nucleotides
which is small enough to not significantly or radically alter the
original sequence's behavior. The percentage of the resulting
portion, with respect to the complete original sequence, that does
not significantly alter such behavior depends on the sequence under
consideration. Or one may insert one or more of the described
mature sequences in an appropriately constructed "container
sequence" (e.g., a precursor-like construct that is different than
the precursor where this mature sequence naturally occurs) that
still permits the excision of effectively the same mature sequence
and thus the generation of an active molecule whose action is
essentially unchanged with respect to that of the molecule
corresponding to the starting mature sequence.
Sequence CWU 0 SQTB SEQUENCE LISTING The patent application
contains a lengthy "Sequence Listing" section. A copy of the
"Sequence Listing" is available in electronic form from the USPTO
web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20080125583A1)-
. An electronic copy of the "Sequence Listing" will also be
available from the USPTO upon request and payment of the fee set
forth in 37 CFR 1.19(b)(3).
0 SQTB SEQUENCE LISTING The patent application contains a lengthy
"Sequence Listing" section. A copy of the "Sequence Listing" is
available in electronic form from the USPTO web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20080125583A1)-
. An electronic copy of the "Sequence Listing" will also be
available from the USPTO upon request and payment of the fee set
forth in 37 CFR 1.19(b)(3).
* * * * *
References